{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:06:53Z","timestamp":1790651213373,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013312","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000}}],"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    Monkeypox virus (MPXV) is emerging as a major concern in the field of infectious diseases. Current treatments are limited, highlighting the need for new therapeutic options. The use of computational methods, such as molecular docking and molecular dynamic (MD) simulations, is a valuable approach in identifying potential compounds that can target specific proteins of the virus, like the DNA polymerase and profilin-like protein profilin-like protein A42R (A42R) in this case, with the aim of controlling the disease. Our study focused on screening various libraries of compounds for predicted binding to MPXV DNA Polymerase (DPol) and A42R proteins, with the top-performing molecules identified based on their docking scores. Among these, Dorsilurin K and Mangostin in complex with DPol, whereas [2-oxo-2-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)anilino]ethyl] 3,5-dimethylbenzoate and N-[4-[2-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]-2-oxoethoxy]phenyl]furan-2-carboxamide in complex with A42R stand out with notably high docking scores, suggesting they may have a good affinity for binding to the DPol and A42R proteins of MPXV respectively. MD simulations confirmed the stability of these ligand-protein complexes followed by evaluation of the ADMET and oral bioavailability analysis. However, it is important that computational methods can suggest promising candidates,\n                    <jats:italic>\n                      <jats:italic>in vitro<\/jats:italic>\n                    <\/jats:italic>\n                    and eventually\n                    <jats:italic>\n                      <jats:italic>in vivo<\/jats:italic>\n                    <\/jats:italic>\n                    studies are essential to validate these therapeutic candidates. Further studies on these compounds will provide insights into their efficacy, safety, and potential side effects. In conclusion, this study offers promising avenues for developing potential treatments for MPXV. If the identified compounds prove effective in further studies, it could be a significant breakthrough in managing this zoonotic disease.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0013312","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T17:40:38Z","timestamp":1753810838000},"page":"e0013312","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Computational screening of antiviral candidates for Monkeypox virus DNA polymerase and A42R protein"],"prefix":"10.1371","volume":"19","author":[{"given":"Muhammad","family":"Amjid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Maroof","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-2519","authenticated-orcid":true,"given":"John B.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"22","key":"pntd.0013312.ref001","doi-asserted-by":"crossref","first-page":"14287","DOI":"10.3390\/ijms232214287","article-title":"Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study","volume":"23","author":"G Preet","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"pntd.0013312.ref002","article-title":"Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation","volume":"14","author":"J Kaler","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"pntd.0013312.ref003","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28036","article-title":"Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022","volume":"95","author":"L Wang","year":"2023","journal-title":"J Med Virol"},{"issue":"3","key":"pntd.0013312.ref004","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/molecules28031444","article-title":"Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I","volume":"28","author":"X Hu","year":"2023","journal-title":"Molecules"},{"issue":"16","key":"pntd.0013312.ref005","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules27165277","article-title":"In Silico Repurposed Drugs against Monkeypox Virus","volume":"27","author":"HYI Lam","year":"2022","journal-title":"Molecules"},{"key":"pntd.0013312.ref006","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.pdpdt.2022.103208","article-title":"Virtual screening and computational simulation analysis of antimicrobial photodynamic therapy using propolis-benzofuran A to control of Monkeypox","volume":"41","author":"M Pourhajibagher","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"8","key":"pntd.0013312.ref007","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/pathogens11080924","article-title":"Monkeypox and Its Possible Sexual Transmission: Where Are We Now with Its Evidence?","volume":"11","author":"R Sah","year":"2022","journal-title":"Pathogens"},{"key":"pntd.0013312.ref008","doi-asserted-by":"crossref","first-page":"106027","DOI":"10.1016\/j.micpath.2023.106027","article-title":"Monkeypox virus: A review","volume":"176","author":"A Letafati","year":"2023","journal-title":"Microb Pathog"},{"issue":"4","key":"pntd.0013312.ref009","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00034-4","article-title":"Mpox respiratory transmission: the state of the evidence","volume":"4","author":"A Beeson","year":"2023","journal-title":"Lancet Microbe"},{"key":"pntd.0013312.ref010","unstructured":"Epidemiological update, week 37\/2024: Mpox due to monkeypox virus clade I. https:\/\/www.ecdc.europa.eu\/en\/news-events\/mpox-monkeypox-epidemiological-update-week-37-2024?utm_source=chatgpt.com. 2025 May 8."},{"issue":"4","key":"pntd.0013312.ref011","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"A Karagoz","year":"2023","journal-title":"J Infect Public Health"},{"issue":"5","key":"pntd.0013312.ref012","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.798","article-title":"Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks","volume":"5","author":"MR Islam","year":"2022","journal-title":"Health Sci Rep"},{"issue":"23","key":"pntd.0013312.ref013","doi-asserted-by":"crossref","first-page":"14259","DOI":"10.1080\/07391102.2023.2183342","article-title":"In silico discovery of potent inhibitors against monkeypox\u2019s major structural proteins","volume":"41","author":"KB Lokhande","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"pntd.0013312.ref014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/v15010251","article-title":"Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors","volume":"15","author":"A Dubey","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"pntd.0013312.ref015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals With Activity Against Mpox: A Clinically Oriented Review","volume":"76","author":"EA Siegrist","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pntd.0013312.ref016","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/v2112409","article-title":"Development of ST-246\u00ae for Treatment of Poxvirus Infections","volume":"2","author":"R Jordan","year":"2010","journal-title":"Viruses"},{"key":"pntd.0013312.ref017","unstructured":"Natural Product Library. https:\/\/www.medchemexpress.com\/screening\/Natural_Product_Library_.html. 2023 October 1."},{"key":"pntd.0013312.ref018","unstructured":"Mumtaz A. MPD3 Guide \u2013 MPD3 Medicinal Plants Database. https:\/\/mpd3.com\/mpd3-guide\/"},{"key":"pntd.0013312.ref019","unstructured":"Compound Libraries for High Throughput\/Content Screening | 96-Well. https:\/\/www.selleckchem.com\/screening\/alkaloid-compound-library.html"},{"key":"pntd.0013312.ref020","unstructured":"Flavonoids Library. https:\/\/www.medchemexpress.com\/screening\/flavonoids-library.html. 2023 October 1."},{"issue":"9","key":"pntd.0013312.ref021","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1089\/cmb.2019.0323","article-title":"Analysis of the Physicochemical Properties of Acaricides Based on Lipinski\u2019s Rule of Five","volume":"27","author":"X Chen","year":"2020","journal-title":"J Comput Biol"},{"key":"pntd.0013312.ref022","doi-asserted-by":"crossref","first-page":"1351737","DOI":"10.3389\/fcimb.2024.1351737","article-title":"Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein","volume":"14","author":"CN Ashley","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"16","key":"pntd.0013312.ref023","article-title":"Structural basis for the assembly of the DNA polymerase holoenzyme from a monkeypox virus variant","volume":"9","author":"Y Li","year":"2023","journal-title":"Sci Adv"},{"key":"pntd.0013312.ref024","volume-title":"The PyMOL Molecular Graphics System, Version 1.8","author":"LLC Schr\u00f6dinger","year":"2015"},{"key":"pntd.0013312.ref025","volume-title":"Molecular Operating Environment (MOE)"},{"issue":"3","key":"pntd.0013312.ref026","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12088-024-01244-3","article-title":"Inhibition of Monkeypox Virus DNA Polymerase Using Moringa oleifera Phytochemicals: Computational Studies of Drug-Likeness, Molecular Docking, Molecular Dynamics Simulation and Density Functional Theory","volume":"64","author":"MA Yousaf","year":"2024","journal-title":"Indian J Microbiol"},{"key":"pntd.0013312.ref027","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1145\/1188455.1188544","article-title":"Molecular dynamics---Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"KJ Bowers","year":"2006","journal-title":"Proceedings of the 2006 ACM\/IEEE conference on Supercomputing - SC \u201906"},{"key":"pntd.0013312.ref028","doi-asserted-by":"crossref","first-page":"611503","DOI":"10.3389\/fcell.2020.611503","article-title":"SHP2 Nuclear\/Cytoplasmic Trafficking in Granulosa Cells Is Essential for Oocyte Meiotic Resumption and Maturation","volume":"8","author":"M Idrees","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"pntd.0013312.ref029","unstructured":"Online SMILES Translator. https:\/\/cactus.nci.nih.gov\/translate\/ 2024 June 20."},{"key":"pntd.0013312.ref030","unstructured":"SwissADME. http:\/\/www.swissadme.ch\/index.php 2024 June 22."},{"issue":"1","key":"pntd.0013312.ref031","doi-asserted-by":"crossref","first-page":"19942","DOI":"10.1038\/s41598-020-77072-4","article-title":"Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation","volume":"10","author":"A Bruzzese","year":"2020","journal-title":"Sci Rep"},{"key":"pntd.0013312.ref032","doi-asserted-by":"crossref","first-page":"130514","DOI":"10.1016\/j.molstruc.2021.130514","article-title":"Synthesis, X-ray crystal structure, IR and Raman spectroscopic analysis, quantum chemical computational and molecular docking studies on hydrazone-pyridine compound: As an insight into the inhibitor capacity of main protease of SARS-CoV2","volume":"1239","author":"T Topal","year":"2021","journal-title":"J Mol Struct"},{"issue":"1","key":"pntd.0013312.ref033","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/07391102.2020.1813628","article-title":"Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses","volume":"40","author":"Z Elkarhat","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"pntd.0013312.ref034","doi-asserted-by":"crossref","first-page":"1095068","DOI":"10.3389\/fmicb.2022.1095068","article-title":"Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation","volume":"13","author":"T Han","year":"2023","journal-title":"Front Microbiol"},{"key":"pntd.0013312.ref035","doi-asserted-by":"crossref","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","article-title":"Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review","volume":"354","author":"S Ghahremanian","year":"2022","journal-title":"J Mol Liq"},{"issue":"4","key":"pntd.0013312.ref036","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1367-5931(99)80058-1","article-title":"Recognizing molecules with drug-like properties","volume":"3","author":"WP Walters","year":"1999","journal-title":"Curr Opin Chem Biol"},{"issue":"3","key":"pntd.0013312.ref037","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0169-409X(02)00003-0","article-title":"Prediction of \u201cdrug-likeness\u201d","volume":"54","author":"WP Walters","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"pntd.0013312.ref038","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6446(01)01712-3","article-title":"Screening for human ADME\/Tox drug properties in drug discovery","volume":"6","author":"AP Li","year":"2001","journal-title":"Drug Discov Today"},{"issue":"9","key":"pntd.0013312.ref039","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"DEV Pires","year":"2015","journal-title":"J Med Chem"},{"issue":"1","key":"pntd.0013312.ref040","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1038\/s41467-020-19594-z","article-title":"Machine learning with physicochemical relationships: solubility prediction in organic solvents and water","volume":"11","author":"S Boobier","year":"2020","journal-title":"Nat Commun"},{"key":"pntd.0013312.ref041","unstructured":"Ascher YM, Alex GC, de Sa D. Deep-PK | Theory. https:\/\/biosig.lab.uq.edu.au\/theory. 2025 May 11."},{"issue":"3","key":"pntd.0013312.ref042","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bpj.2014.06.024","article-title":"A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations","volume":"107","author":"TS Carpenter","year":"2014","journal-title":"Biophys J"},{"key":"pntd.0013312.ref043","unstructured":"Lipinski\u2019s Rule of Five - an overview. https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/lipinskis-rule-of-five. 2023 October 12."},{"key":"pntd.0013312.ref044","unstructured":"PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/#query=COC1%3DC(CC%3DC(C)C)C2%3DC(O)C3%3DC(OC2%3DCC1%3DO)C%3DC(O)C(%3DC3O)CC%3DC(C)C. 2024 June 20."},{"key":"pntd.0013312.ref045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijbiomac.2022.12.252","article-title":"Identification of probable inhibitors for the DNA polymerase of the Monkeypox virus through the virtual screening approach","volume":"229","author":"S Kumari","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"pntd.0013312.ref046","first-page":"14","article-title":"Viral infectious disease and natural products with antiviral activity","volume":"1","author":"K Kitazato","year":"2007","journal-title":"Drug Discov Ther"},{"issue":"22","key":"pntd.0013312.ref047","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.3390\/molecules27227718","article-title":"Identification of Antiviral Compounds against Monkeypox Virus Profilin-like Protein A42R from Plantago lanceolata","volume":"27","author":"LH Bajrai","year":"2022","journal-title":"Molecules"},{"key":"pntd.0013312.ref048","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jtcme.2023.04.002","article-title":"Computational studies on searching potential phytochemicals against DNA polymerase activity of the monkeypox virus","volume":"13","author":"S Vardhan","year":"2023","journal-title":"Journal of Traditional and Complementary Medicine"},{"key":"pntd.0013312.ref049","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-981-15-1761-7_12","article-title":"Phytochemicals as Antiviral Agents: Recent Updates","author":"R Ghildiyal","year":"2020","journal-title":"Plant-derived Bioactives. Springer Singapore"},{"issue":"3","key":"pntd.0013312.ref050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"ML Landry","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0013312.ref051","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ab.2017.01.015","article-title":"Correlation between luminescence intensity and cytotoxicity in cell-based cytotoxicity assay using luciferase","volume":"522","author":"S Wakuri","year":"2017","journal-title":"Anal Biochem"},{"key":"pntd.0013312.ref052","doi-asserted-by":"crossref","first-page":"115163","DOI":"10.1016\/j.jviromet.2025.115163","article-title":"Development of neutralization tests using single-round infectious particles and cytopathic effect as an alternative method for measuring antibody titers against Japanese encephalitis virus in national epidemiological surveillance program of vaccine-preventable diseases in Japan","volume":"336","author":"S Yazawa","year":"2025","journal-title":"J Virol Methods"},{"key":"pntd.0013312.ref053","doi-asserted-by":"crossref","first-page":"151560","DOI":"10.1016\/j.bbrc.2025.151560","article-title":"Myricetin supresses HBV replication both in vitro and in vivo via inhibition of HBV promoter SP2","volume":"755","author":"L Lu","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"pntd.0013312.ref054","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13104-025-07143-0","article-title":"Antiviral activity of silver nanoparticles against H1N1 influenza virus","volume":"18","author":"M Seyfi","year":"2025","journal-title":"BMC Res Notes"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013312","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:48:30Z","timestamp":1756403310000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013312"}},"subtitle":[],"editor":[{"given":"David","family":"Safronetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013312","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}